A physiologically based pharmacokinetic model for [68Ga]Ga-(HA-)DOTATATE to predict whole-body distribution and tumor sink effects in GEP-NET patients
Abstract Background Little is known about parameters that have a relevant impact on (dis)similarities in biodistribution between various 68Ga-labeled somatostatin analogues. Additionally, the effect of tumor burden on organ uptake remains unclear. Therefore, the aim of this study was to describe and...
Main Authors: | Hinke Siebinga, Berlinda J. de Wit-van der Veen, Jos H. Beijnen, Thomas P. C. Dorlo, Alwin D. R. Huitema, Jeroen J. M. A. Hendrikx |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2023-02-01
|
Series: | EJNMMI Research |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13550-023-00958-7 |
Similar Items
-
Predicting [177Lu]Lu-HA-DOTATATE kidney and tumor accumulation based on [68Ga]Ga-HA-DOTATATE diagnostic imaging using semi-physiological population pharmacokinetic modeling
by: Hinke Siebinga, et al.
Published: (2023-08-01) -
A physiologically based pharmacokinetic (PBPK) model to describe organ distribution of 68Ga-DOTATATE in patients without neuroendocrine tumors
by: H. Siebinga, et al.
Published: (2021-08-01) -
Semiquantitative Analysis of Physiological Biodistribution of <sup>68</sup>Ga-DOTATATE and <sup>68</sup>Ga-DOTANOC
by: Evrim SÜRER BUDAK, et al.
Published: (2023-07-01) -
Gastrointestinal neuroendocrine tumor with discordant metastatic disease on 111In-pentetreotide SPECT/CT, 18F-DOPA PET/CT and 68Ga-HA-DOTATATE PET/CT
by: Katrin Resch, et al.
Published: (2022-07-01) -
Ga-68 DOTATATE PET/CT in a patient with Zollinger-Ellison syndrome
by: Migara Jayasekera, BS, et al.
Published: (2023-03-01)